TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Revvity Inc. (RVTY)

Healthcare Diagnostics & Research
115.20 $
+2.4% vs. previous close
Closing price · As of: 3. Aug 2026

Revvity Inc. (RVTY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Revenue" came in at 711 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Income Statement RVTY
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 LTM
709 671 696 650 692 684 729 665 720 699 772 711 2,902
307 298 402 295 306 299 370 289 328 324 434 323 1,409
402 373 294 355 386 385 360 376 393 375 338 388 1,493
57 53 50 50 48 49 49 54 53 51 58 58 220
269 251 252 262 254 239 239 250 250 242 252 254 998
291 279 195 281 284 282 227 303 302 293 226 312 1,133
111 93 99 74 102 103 132 72 91 82 112 76 360
26 25 25 24 25 24 23 23 23 23 24 25 94
72 51 31 35 87 100 95 52 69 56 92 50 266
13 18 -32 5.9 14 7.0 6.2 11 13 8.5 -6.8 9.1 24
36 9.6 103 28 79 94 95 42 55 47 98 41 241
206 184 162 167 219 232 222 173 194 181 218 180 773

LTM = last twelve months (sum of the four most recent quarters).

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?